340B omnibus guidance withdrawn

AHA News Now

The administration yesterday withdrew the Health Resources and Services Administration’s pending omnibus guidance for the 340B Drug Pricing Program. “We are pleased that the Administration chose not to finalize the Health Resources and Services Administration’s guidance, which, if enacted would have... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA issues final rule on 340B drug ceiling prices, manufacturer penalties

AHA News Now

The Health Resources and Services Administration today released a final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program. Required by the Affordable Care Act, the rule amends Section 340B of the Public Health Service Act to impose monetary... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation, drug prices

AHA calls proposed rule on 340B dispute resolution process 'an important first step'

AHA News Now

The Health Resources and Services Administration’s proposed rule that would establish an administrative dispute resolution process for the 340B Drug Pricing Program “is an important first step for 340B hospitals and clinics that have been overcharged for drugs purchased through the program,” but there are... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation

AHA expresses support for Closing Loopholes for Orphan Drugs Act

AHA News Now

The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act (H.R. 6174), bipartisan legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals. Specifically, the legislation would allow 340B critical access hospitals, sole community... read more

Topic: Advocacy and Public Policy
Tag: 340B

Reminder: 2018 essential community provider applications due Oct. 15

AHA News Now

Hospitals that serve predominantly low-income, medically-underserved individuals may submit an application to the Centers for Medicare & Medicaid Services through Oct. 15 to add their facility to the Essential Community Provider list for the 2018 Health Insurance Marketplaces. Eligible hospitals include... read more

Topic: Advocacy and Public Policy
Tags: 340B, Coverage, rural, Critical Access Hospitals, RRC

Sept. 7 deadline for hospitals to recertify for 340B program

AHA News Now

Tomorrow is the last day that hospitals can recertify for the 340B Drug Pricing Program. All 340B hospitals are required to recertify annually with the Health Resources and Services Administration to ensure they continue to meet 340B hospital eligibility requirements. To access a recent HRSA webinar on... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA proposed rule would establish dispute resolution process for 340B program

AHA News Now

The Health Resources and Services Administration today released a proposed rule that would implement an Affordable Care Act provision requiring a binding administrative dispute resolution process for 340B Drug Pricing Program participants who claim they have been overcharged for drugs purchased through... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation

HRSA webinar tomorrow to discuss 340B recertification

AHA News Now

The Health Resources and Services Administration's Office of Pharmacy Affairs will host a webinar July 20 to assist covered entities with the recertification process for the 340B Drug Pricing Program. Hospitals can join the webinar, from 1 p.m. to 2 p.m. ET, by visiting ... read more

Topic: Advocacy and Public Policy
Tag: 340B

AHASTAT Blog: Hospitals and 340B program help preserve, protect the safety-net

AHA News Now

Hospitals, including those participating in the 340B Drug Pricing Program, are the true safety-net, not the pharmaceutical industry with its “skyrocketing prescription drug prices and huge profits,” AHA Executive Vice President Tom Nickels writes in an AHASTAT blog post today. Nickels notes that hospitals... read more

Topic: Advocacy and Public Policy
Tag: 340B

Hospitals, not pharmaceutical manufacturers, are preserving and protecting the safety net

Blog

A group financed by the pharmaceutical industry is hosting a meeting today on the 340B Drug Pricing Program with the goal of “Preserving the True Safety Net.” But what the meeting really will be about is the pharmaceutical industry – with their skyrocketing prescription drug prices and huge profits –... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, Community benefit, access, drug prices

Keyword Search

Date